| Research Topics: |
| INDEX |
| AI-chat 3 |
| MCS 2 |
| PRIME 24 |
| aging 16 |
| brain 8 |
| brainwave 2 |
| cancer 11 |
| climate 1 |
| cognition 5 |
| covid-19 2 |
| culture 4 |
| dental 1 |
| diabetes 5 |
| diagnostics 1 |
| drugs 5 |
| ears 1 |
| exercise 1 |
| eyes 1 |
| gender 2 |
| genetics 5 |
| gut 3 |
| heart 8 |
| immune 9 |
| language 1 |
| lyme 1 |
| microbiome 3 |
| misc |
| music 1 |
| nutrition 9 |
| obesity 2 |
| pain 2 |
| physical 3 |
| politics 2 |
| pollution 2 |
| practice 2 |
| psychology 6 |
| quantum 2 |
| reproduction 1 |
| rights 1 |
| sleep 1 |
| soc-media |
| tech 1 |
| vaccine 1 |
| war-confl |
|
Scanned: 3107 Evaluated: 147 Selected: 74 |
| PRIME BRAIN BRAINWAVE | ||||||||
Mne37-003 | Target-dependent parameter-effect landscapes of low-intensity focused ultrasound neuromodulation in humans: a systematic review | |||||||
| Quote: | These findings challenge the assumption that acoustic protocols have generalizable effects across the brain and identify anatomical target as a central dimension that should inform LIFU protocol design. We provide SonoMap, an open, interactive web resource that supports a more systematic, evidence-based approach to human LIFU neuromodulation. | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.09.11.26362849v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.09.11.26362849v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Hyunwoo Jang Krishna Swetha Meka Andrew Yang George A. Mashour Anthony G Hudetz Zirui Huang, | |||||||
| PRIME BRAIN BRAINWAVE DRUGS PSYCHOLOGY | ||||||||
Mpy37-018 | DMN-Targeted TMS Reduces Neural Cue-Reactivity in Individuals with Schizophrenia who Use Nicotine | |||||||
| Quote: |
Background: Nicotine dependence is a major contributor to early
mortality in individuals with schizophrenia, yet effective treatments
remain limited. Drug cue-reactivity is a key contributor to nicotine
use. Although transcranial magnetic stimulation (TMS) can reduce
nicotine use and cue-reactivity, conventional left dorsolateral
parietal (DLPFC)-targeted TMS is less effective in those with
schizophrenia, highlighting the need for alternative, circuit-based
targets....
Conclusion: DMN-targeted TMS is a promising intervention that modulates nicotine cue-elicited brain activity in schizophrenia. | |||||||
| Comment: | Pierson and Shaw, in their book series Life Extension, wrote that Niacin provides a kind of sensory buffer that some smokers need while quitting. Hoffer also found that Niacin can refere schizophrenia in some patients due to a genetic defect preventing them from converting Tryptophan to Niacin. | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.09.15.26363162v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.09.15.26363162v1 .full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Yunong Bai Anna Huang Jillian Connolly Sophia H Blyth Simon Vandekar Baxter P Rogers Libby Tunison Catie Chang Hilary Tindle Stephan Heckers Roscoe O Brady Amy Janes Heather Burrell Ward, | |||||||
|
Javilk's Research Links Newsletter for Week 37 Updated 09/19/2026-02:54:36 AM What interests you? What have you found? Tell me! Drop me a note at Javilk.com to subscribe or submit something. |